Kathmere Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Kathmere Capital Management's LLY Position: Q3 2026 in Review
Kathmere Capital Management increased its Eli Lilly (LLY) stake by 9.3% in Q3 2026, buying an estimated $507K and bringing the position to 5,056 shares worth $5.85M. The position accounts for 0.28% of the portfolio, ranked #66.
Kathmere Capital Management first reported a position in LLY in Q1 2022 and has held it in 19 quarters since. 3,033 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Kathmere Capital Management held 5,056 shares of Eli Lilly worth $5.85M as of Q3 2026.
- Kathmere Capital Management bought 430 Eli Lilly shares in Q3 2026, an estimated $507K.
- Eli Lilly made up 0.28% of Kathmere Capital Management's portfolio in Q3 2026, its #66 holding.
- Kathmere Capital Management first reported a position in Eli Lilly in Q1 2022 and has held it in 19 quarters since.
- 3,033 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Kathmere Capital Management's 13F filing for Q3 2026, filed 20 Oct 2026.